Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Trial Profile

Effects of Riluzole on CNS Glutamate and Fatigue in Breast Cancer Survivors With High Inflammation

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Jun 2018

At a glance

  • Drugs Riluzole (Primary)
  • Indications Fatigue; Inflammation
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Jun 2018 Planned End Date changed from 1 Nov 2018 to 1 Nov 2019.
    • 06 Jun 2018 Planned primary completion date changed from 1 Nov 2018 to 1 Nov 2019.
    • 07 Dec 2017 Planned End Date changed from 1 Nov 2017 to 1 Nov 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top